Neoleukin Therapeutics

NLTX NASDAQ
3.900
-0.050
-1.27%
已收盘, 16:00 08/19 EDT
开盘
4.050
昨收
3.950
最高
4.100
最低
3.830
成交量
20.08万
成交均量(3M)
12.33万
52周最高
4.230
52周最低
2.000
换手率
0.85%
市值
9,179.57万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Neoleukin Therapeutics NLTX股票价格,Neoleukin Therapeutics股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Neoleukin Therapeutics, Inc., formerly Aquinox Pharmaceuticals, Inc., is a biopharmaceutical company. The Company is focused on the development and commercialization of computationally-designed protein therapeutics to address unmet medical needs in immuno-oncology, inflammation, and autoimmunity. Its computational platform allows it to design new de novo proteins to treat serious diseases, including cancer, inflammatory, and autoimmune disorders. Its lead program, NL-201, is a computationally-designed de novo protein therapeutic. NL-201 is a combined IL-2 and IL-15 agonist designed to eliminate alpha receptor binding. NL-201 is designed for use as a single-agent or in combination with complementary therapeutic modalities.
展开 >

最近浏览

名称
价格
涨跌幅